Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-07 · accession 0001437749-25-007044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-11 | 2025-03-07 | LMAT | Roberts David B | Pres, Dir | M - OptEx | $35.48 | +2,818 | 18.0K | +19% | +$100.0K |
| D | 2025-03-11 | 2025-03-07 | LMAT | Roberts David B | Pres, Dir | M - OptEx | $0.00 | -2,818 | 123 | -96% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-07 | M | A | 2,818 | $35.48 | 17,976 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-03-07 | M | D | 2,818 | $0.00 | 123 | D | $35.48 · 2019-12-20 to 2026-12-20 | 2,818 Common Stock | (F2) This option is fully vested and exercisable. |